Results 271 to 280 of about 31,826 (289)

ECONOMIC CONCENTRATIONS OF TRIAMCINOLONE ACETONIDE.

British Journal of Dermatology, 1962
openaire   +3 more sources

Fluocinolone acetonide for the treatment of diabetic macular edema

Expert Opinion on Pharmacotherapy, 2017
Daniele Veritti, Valentina Sarao, L. Diplotti, F. Samassa, P. Lanzetta   +4 more
semanticscholar   +1 more source

Long-term follow-up of Dupuytren disease after injection of triamcinolone acetonide in Chinese patients in Taiwan

Journal of Hand Surgery (European Volume), 2017
Chong Yin, H. Yu, J-P Wang, Y.-C. Huang, T.-F. Huang, M-C Chang   +5 more
semanticscholar   +1 more source

Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.

Journal of Controlled Release, 2015
Mei Chen, Xiaoli Li, Jinkun Liu, Yin Han, Lingyun Cheng   +4 more
semanticscholar   +1 more source

Depigmentation due to Triamcinolone Acetonide

Exogenous Dermatology, 2004
Tokio Nakada, Masafumi Iijima, Rei Sagara   +2 more
openaire   +2 more sources

Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa

Acta Ophthalmologica, 2005
exaly  

Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases

Acta Ophthalmologica, 2005
Jost B Jonas
exaly  

IOP after Triamcinolone Acetonide

Ophthalmology, 2005
Yi-Yu Tsai, Jane-Ming Lin, Por-Tying Hung   +2 more
openaire   +2 more sources

Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC‐II in exudative age‐related macular degeneration

Clinical and Experimental Ophthalmology, 2001
exaly  

Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6‐month results of a prospective controlled trial

Acta Ophthalmologica, 2006
Alain Gaudric, Jean-françois Bergmann
exaly